Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Maravai Lifesciences Holdings (MRVI) Enterprise Value: 2020-2025

Historic Enterprise Value for Maravai Lifesciences Holdings (MRVI) over the last 5 years, with Sep 2025 value amounting to $675.7 million.

  • Maravai Lifesciences Holdings' Enterprise Value fell 62.16% to $675.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$203.0 million, marking a year-over-year decrease of 392.77%. This contributed to the annual value of $1.3 billion for FY2024, which is 25.10% down from last year.
  • Per Maravai Lifesciences Holdings' latest filing, its Enterprise Value stood at $675.7 million for Q3 2025, which was up 23.77% from $545.9 million recorded in Q2 2025.
  • Maravai Lifesciences Holdings' 5-year Enterprise Value high stood at $10.9 billion for Q2 2021, and its period low was $506.7 million during Q1 2025.
  • Its 3-year average for Enterprise Value is $1.7 billion, with a median of $1.7 billion in 2023.
  • As far as peak fluctuations go, Maravai Lifesciences Holdings' Enterprise Value skyrocketed by 41.00% in 2021, and later slumped by 74.47% in 2025.
  • Maravai Lifesciences Holdings' Enterprise Value (Quarterly) stood at $10.3 billion in 2021, then plummeted by 66.69% to $3.4 billion in 2022, then tumbled by 49.20% to $1.7 billion in 2023, then dropped by 25.10% to $1.3 billion in 2024, then plummeted by 62.16% to $675.7 million in 2025.
  • Its Enterprise Value stands at $675.7 million for Q3 2025, versus $545.9 million for Q2 2025 and $506.7 million for Q1 2025.